Home
/
Vaxart, Inc.
/
Financials
/
Quarterly
Vaxart, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Vaxart, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$72.41M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$39.73M
Aug 13, 2025
Q1
2025
Mar 31, 2025
$20.88M
May 13, 2025
Q3
2025
Sep 30, 2024
$4.93M
Nov 13, 2025
Q2
2025
Jun 30, 2024
$6.40M
Aug 13, 2025
Q1
2025
Mar 31, 2024
$2.18M
May 13, 2025
Q3
2024
Sep 30, 2023
$2.10M
Nov 13, 2024
Q2
2024
Jun 30, 2023
$1.36M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$675.0K
May 13, 2024
Q1
2019
Mar 31, 2019
$5.41M
May 9, 2019
Q3
2018
Sep 30, 2018
$281.0K
Nov 13, 2018
Q2
2018
Jun 30, 2018
$608.0K
Aug 10, 2018
Q1
2019
Mar 31, 2018
$1.50M
May 9, 2019
Q2
2018
Dec 31, 2017
$2.70M
Feb 6, 2018
Q1
2018
Sep 30, 2017
$100.0K
Nov 7, 2017
Q3
2018
Sep 30, 2017
$915.0K
Nov 13, 2018
Q2
2018
Jun 30, 2017
$1.85M
Aug 10, 2018
Q3
2017
Mar 31, 2017
$4.90M
May 8, 2017
Q1
2018
Mar 31, 2017
$2.31M
May 15, 2018
Q2
2018
Dec 31, 2016
$3.80M
Feb 6, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.14M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($14.99M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($15.59M)
May 13, 2025
Q3
2025
Sep 30, 2024
($14.08M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($16.47M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($24.42M)
May 13, 2025
Q3
2024
Sep 30, 2023
($17.40M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($22.55M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($25.14M)
May 13, 2024
Q3
2023
Sep 30, 2022
($29.31M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($29.43M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($25.10M)
May 4, 2023
Q3
2022
Sep 30, 2021
($17.58M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($16.12M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($16.01M)
May 9, 2022
Q3
2021
Sep 30, 2020
($8.09M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($8.98M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($1.30M)
May 6, 2021
Q3
2020
Sep 30, 2019
($5.26M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($5.64M)
Aug 6, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.81M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($14.60M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($14.94M)
May 13, 2025
Q3
2025
Sep 30, 2024
($14.48M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($16.26M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($24.07M)
May 13, 2025
Q3
2024
Sep 30, 2023
($17.82M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($23.05M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($25.57M)
May 13, 2024
Q3
2023
Sep 30, 2022
($29.43M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($29.25M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($24.78M)
May 4, 2023
Q3
2022
Sep 30, 2021
($17.25M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($15.78M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($15.51M)
May 9, 2022
Q3
2021
Sep 30, 2020
($7.59M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($8.53M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($694.0K)
May 6, 2021
Q3
2020
Sep 30, 2019
($4.71M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($5.00M)
Aug 6, 2020